New class of drug offers hope to treatment-resistant AIDS patients

For the estimated millions of AIDS patients worldwide who are resistant or are developing resistance to currently available medicines, a discovery by a University of Georgia researcher may offer a new treatment option by targeting a previously elusive enzyme in the complex retrovirus responsible for the devastating disease.

If you want to include this story in your blog, copy and paste this formatted text: